Rishikesh Exports: Unleashing Next-Gen Pharma With Smart & Sustainable Execution

Avinash Shahane & Prashant Lolage, Managing Partners

Avinash Shahane & Prashant Lolage

Managing Partners

Pharma Turnkey Project Consultants play a pivotal role in transforming visionary ideas into fully operational, regulatory-compliant manufacturing units. With the global pharmaceutical market projected to exceed $1.6 tril­lion by 2030, investors, ranging from seasoned MNCs to new entrants are increasingly seeking expert partners who can deliver holistic, future-ready solutions. These consultants of­fer end-to-end services including conceptual design, detailed engineering, equipment selection, utility planning, validation, and regulatory compliance, ensuring that clients meet strin­gent global standards without cost overruns. Rishikesh Ex­ports stands out in this space by offering comprehensive, tai­lor-made turnkey solutions under one roof, backed by global experience across 17+ countries, unmatched transparency, and a commitment to 100 percent client satisfaction.

Established with a clear vision to deliver comprehensive engineering solutions, the company began its journey by catering to the daily consumable requirements of its customers. Initially constrained by financial limitations and the need to build credentials, it quickly evolved, earning trust and taking on larger assignments. Within a few years, Rishikesh Exports transitioned from supplying consumables to manufacture specialized equipment such as dryers, granulators, mixers, and reactors, eventually graduating to assembling equipment and executing full-fledged Turnkey Projects.

The company operates across four primary verticals including Healthcare & Pharma, Food, Power & Energy, and Utilities. In the healthcare domain, it caters to pharmaceuticals, cosmetics, nutraceuticals, and herbal extract sectors. The food segment involves specialized projects in sugar, coconut, and instant tea, while spice and essential oil extractions are categorized under herbal and pharmaceutical applications due to their medicinal value. The power and energy verticals focuses on process industry solutions such as boilers, turbines, biogas generation, and effluent management. Complementing these are the Utilities division, which provides critical support through consumables and spares, maintaining customer engagement and honoring the company's foundational roots.

“We have been export-focused since the beginning, with over 90 percent of our revenue comes from global markets, helping boost foreign exchange earnings. Our strong focus on quality, innovation, and customer needs have made us a trusted engineering partner across countries”, informs Prashant Lolage, Managing Partner, Rishikesh Exports.

We ensure synchronized coordination across departments and deliver turnkey projects within budget and timelines by simplifying complex executions

Avinash Shahane & Prashant Lolage, Managing Partners

Integrated Turnkey Solutions

Rishikesh Exports has established itself as a distinguished LSTK (Lump Sum Turnkey) and EPC (Engineering, Procurement, and Consulting ) solution provider, offering a comprehensive, integrated approach to project execution across its key verticals. The company’s turnkey model is designed to provide end-to-end support, beginning right from design and conceptualization. This initial stage involves a high-level understanding of client objectives, site area requirements, basic investment estimates, and output projections, helping stakeholders at the top decision-making levels visualize project viability. Once the initial framework is agreed upon, the coampany undertakes detailed engineering, including process flow diagrams, plant layouts, utility planning (like HVAC systems, boilers, compressors, and more), and lab setups, along with precise cost estimations.

What sets Rishikesh Exports apart is its commitment to minimizing exclusions and ensuring full project transparency. While most EPC players leave significant gaps in scope, often leading to cost overruns or delays, the company ensures a well-defined deliverable structure, excluding only essentials like land, civil works, and local approvals. The transparency and on-time delivery have helped the company build long-standing global relationships, with repeat orders from over 17 countries in Southeast Asia, the Middle East, and Africa.

Particularly in the pharmaceutical vertical, Rishikesh Exports bring unmatched depth by integrating engineering with formulation, analytical stability, validation, and regulatory compliance, areas often managed separately by multiple vendors. “We offer all these competencies under one roof to eliminate inter-vendor conflicts and execution delays. This integrated approach is especially critical in high-regulation segments like oncology, MDI/DPI, and sterile manufacturing, where precision and compliance are paramount”, asserts Prashant.

Tackling Real-World Challenges

Implementing turnkey pharmaceutical projects comes with inherent complexities, and Rishikesh Exports addresses these challenges with a pragmatic and deeply integrated approach. “Despite thorough planning through URS, design qualifications, and technical documentation, real-time project execution often reveals afterthoughts and unforeseen modifications, either during FAT, SAT, or post-installation. We not only anticipate such scenarios but also address them with flexibility and minimal burden on the client”, adds Prashant.

A significant advantage lies in the company’s in-house manufacturing capabilities, unlike many consultants who rely entirely on outsourced equipment. This dual role as engineering expert and manufacturer enhances quality control, delivery timelines, and overall execution efficiency. Common on-ground challenges include unreported changes in site civil works, regulatory non-compliance, and substandard material use, such as outdated asbestos panels in cleanrooms, which pose critical risks to GMP adherence. The company often encounters ill-informed choices made in the name of cost-saving, such as replacing boiler systems with non-viable electric heating or implementing non-compliant water lines. Despite these issues, Rishikesh Exports maintains its commitment to quality, often accommodating last-minute changes without escalating costs.

Integrating Sustainability Through Technology

Rishikesh Exports ensures that the facilities are technologically advanced, sustainable, and adaptable to future industry shifts. Its turnkey projects are engineered with modular designs and smart automation systems including PLC, SCADA, and HMI controls. These systems offer precision, real-time data monitoring, and process standardization, laying the foundation for seamless integration of emerging technologies like Artificial Intelligence (AI), Machine Learning (ML), IoT, and Building Information Modeling (BIM). Such technologies are pivotal in enhancing production efficiency, traceability, and predictive maintenance.

In parallel, Rishikesh Exports places a strong emphasis on sustainability. From zero liquid discharge (ZLD) solutions and waste-to-energy systems to solar rooftop integration and energy-efficient process designs, every project is structured to minimize environmental impact and operational costs. In a landscape that is evolving at an unprecedented pace, Rishikesh Exports stands out by delivering solutions and services that are not only ready for today but built for tomorrow.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest


© 2026 India Pharma Outlook. All Rights Reserved.